Literature DB >> 4244303

Activation of coagulase clotting by trypsin inhibitor.

D S Orth, A W Anderson, M W Montgomery.   

Abstract

Egg white trypsin inhibitor activated coagulase clotting when added to a final concentration between 2 and 60 mg/ml. The greatest increase in clotting rate was observed in reaction mixtures containing the lowest concentrations of serum and plasma. Maximal activation was reached with 40 mg of trypsin inhibitor per ml when either serum or plasma was used as the source of coagulase-reacting factor (CRF). The increased rate of clotting is partly due to inhibition of plasmin. Freezing and thawing reduced plasma clotting inhibition. Soybean trypsin inhibitor also activated the coagulase reaction. The increased rate of clotting was observed with a coagulase preparation from organisms which produced plasminogen activators and with the culture supernatant fraction from organisms which did not activate plasminogen to plasmin. The tube test for coagulase could be made more sensitive for some strains of staphylococci by increasing the concentration of CRF (added as plasma or serum) by adding trypsin inhibitor, or both.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4244303      PMCID: PMC378111          DOI: 10.1128/am.18.5.906-910.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Muller's phenomenon and its relationship to plasminogen activation and to blood constituents producing opacity in an agar gel.

Authors:  J G HUTCHISON
Journal:  J Pathol Bacteriol       Date:  1962-10

2.  Studies on staphylococcal infections. I. Interrelation of phage type and some physiological properties of staphylococci, with special reference to the Muller factor.

Authors:  N M TAURASO; D A WHITE
Journal:  Am J Dis Child       Date:  1963-02

3.  Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase-reacting factor and their inhibition by disopropylfluophosphate.

Authors:  M C DRUMMOND; M TAGER
Journal:  J Bacteriol       Date:  1962-05       Impact factor: 3.490

4.  Purification of staphylococcal coagulase.

Authors:  H BLOBEL; D T BERMAN; J SIMON
Journal:  J Bacteriol       Date:  1960-06       Impact factor: 3.490

5.  The use of a lyophilized human plasma standardized for blood coagulation factors in the coagulase and fibrinolytic tests.

Authors:  F J TURNER; B S SCHWARTZ
Journal:  J Lab Clin Med       Date:  1958-12

6.  Problems in the coagulation of plasma by staphylocoagulase.

Authors:  M TAGER
Journal:  Ann N Y Acad Sci       Date:  1956-08-31       Impact factor: 5.691

7.  The action of thrombin on synthetic substrates.

Authors:  S SHERRY; W TROLL
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

8.  Determination of trypsin inhibitor in blood plasma.

Authors:  S F McCANN; M LASKOWSKI
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

9.  Staphylococcal coagulase; mode of action and antigenicity.

Authors:  E S DUTHIE; L L LORENZ
Journal:  J Gen Microbiol       Date:  1952-02

10.  The activation of staphylococcal free coagulase by plasma constituents and the hydrolysis of Nalpha-toluene-p-sulphonyl-L-arginine methyl ester (TAME) by activated coagulase.

Authors:  G HAUGHTON; E S DUTHIE
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

  10 in total
  2 in total

1.  Comparison of animal sera for suitability in coagulase testing.

Authors:  D S Orth; L R Chugg; A W Anderson
Journal:  Appl Microbiol       Date:  1971-03

2.  Polymyxin-coagulase-mannitol-agar. I. A selective isolation medium for coagulase-positive Staphylococci.

Authors:  D S Orth; A W Anderson
Journal:  Appl Microbiol       Date:  1970-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.